FIELD: medicine.
SUBSTANCE: correction of lipid composition of thrombocyte membranes in patients suffering from metabolic syndrome (MS) is enabled with three-month individually prescribed hypo-calorie diet, graduated physical activity and preparations Pioglitazone dosed 30 mg once a day, Irbesartan dosed 150 mg once a day and Lerkanidipine dosed 10 mg in the morning.
EFFECT: normalisation of lipid composition of thrombocyte membranes in patients suffering from metabolic syndrome and ensured functioning level specific for healthy people resulted from three-month treatment.
1 ex
Authors
Dates
2009-02-10—Published
2007-07-09—Filed